Skip to main content
. 2022 Mar 24;16:854992. doi: 10.3389/fnins.2022.854992

FIGURE 2.

FIGURE 2

Current AD treatments and targets. Panel (A) commonly accepted AD disease progression pathway while highlighting commonly targeted pathways in AD therapeutics, (B) visualization of the time point those therapies are tackling in respect to the progression of the disease. Portions of the figure was created with BioRender.com.